These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37272673)

  • 41. Growing Spectrum of Autoimmune Nodopathies.
    Gupta P; Mirman I; Shahar S; Dubey D
    Curr Neurol Neurosci Rep; 2023 May; 23(5):201-212. PubMed ID: 37014546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies.
    Briani C; Visentin A
    Neurotherapeutics; 2022 Apr; 19(3):874-884. PubMed ID: 35349079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathogenesis of immune-mediated neuropathies.
    Dalakas MC
    Biochim Biophys Acta; 2015 Apr; 1852(4):658-66. PubMed ID: 24949885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
    Manso C; Querol L; Mekaouche M; Illa I; Devaux JJ
    Brain; 2016 Jun; 139(Pt 6):1700-12. PubMed ID: 27017186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains.
    Pillai AM; Thaxton C; Pribisko AL; Cheng JG; Dupree JL; Bhat MA
    J Neurosci Res; 2009 Jun; 87(8):1773-93. PubMed ID: 19185024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathophysiology of autoimmune polyneuropathies.
    Dalakas MC
    Presse Med; 2013 Jun; 42(6 Pt 2):e181-92. PubMed ID: 23642299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conduction block in immune-mediated neuropathy: paranodopathy versus axonopathy.
    Garg N; Park SB; Howells J; Vucic S; Yiannikas C; Mathey EK; Nguyen T; Noto Y; Barnett MH; Krishnan AV; Spies J; Bostock H; Pollard JD; Kiernan MC
    Eur J Neurol; 2019 Aug; 26(8):1121-1129. PubMed ID: 30882969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoimmune Peripheral Neuropathies and Contribution of Antiganglioside/Sulphatide Autoantibody Testing.
    Roggenbuck D; Delmont E; Reinhold D; Schierack P; Conrad K; Boucraut J
    Mediterr J Rheumatol; 2020 Mar; 31(1):10-18. PubMed ID: 32411930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inflammatory neuropathies.
    Hughes RA
    Baillieres Clin Neurol; 1994 Apr; 3(1):45-72. PubMed ID: 7921591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative bioptic and electrophysiological investigations in polyneuropathies (author's transl)].
    Sluga E; Mamoli B; Pateisky K
    Wien Klin Wochenschr; 1977 Feb; 89(4):113-22. PubMed ID: 836614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nerve conduction studies in polyneuropathy: practical physiology and patterns of abnormality.
    Franssen H; van den Bergh PY
    Acta Neurol Belg; 2006 Jun; 106(2):73-81. PubMed ID: 16898257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.
    Tang L; Huang Q; Qin Z; Tang X
    J Neurol; 2021 Aug; 268(8):2757-2768. PubMed ID: 32266541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical profile of autoimmune nodopathy with anti-neurofascin 186 antibody.
    Liu B; Zhou L; Sun C; Wang L; Zheng Y; Hu B; Qiao K; Zhao C; Lu J; Lin J
    Ann Clin Transl Neurol; 2023 Jun; 10(6):944-952. PubMed ID: 37060203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atypical Electrophysiological Findings in a Patient with Acute Motor and Sensory Axonal Neuropathy.
    Versace V; Campostrini S; Tezzon F; Martignago S; Kofler M; Saltuari L; Sebastianelli L; Nardone R
    Front Neurol; 2017; 8():594. PubMed ID: 29167658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic neuropathies - chronic inflammatory demyelinating neuropathy and its variants.
    Ramchandren S; Lewis RA
    Front Neurol Neurosci; 2009; 26():12-25. PubMed ID: 19349703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiology of immune-mediated demyelinating neuropathies-part I: neuroscience.
    Franssen H; Straver DC
    Muscle Nerve; 2013 Dec; 48(6):851-64. PubMed ID: 24006203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Axonal multifocal motor neuropathy without conduction block or other features of demyelination.
    Katz JS; Barohn RJ; Kojan S; Wolfe GI; Nations SP; Saperstein DS; Amato AA
    Neurology; 2002 Feb; 58(4):615-20. PubMed ID: 11865141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Axonal involvement in dysimmune neuropathies].
    Vallat JM
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S5-11. PubMed ID: 18087224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antisulfatide antibodies in neuropathy: clinical and electrophysiologic correlates.
    Dabby R; Weimer LH; Hays AP; Olarte M; Latov N
    Neurology; 2000 Apr; 54(7):1448-52. PubMed ID: 10751255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.